Why I Stopped BPC-157 and TB-500 Peptides - April 26, 2024
Summary
TLDRIn this video, the speaker shares an update on their peptide therapy journey using BPC-157 and TB-500. After two months, they decided to pause treatment due to persistent soreness, despite experiencing strength and mobility improvements. They discovered that their lack of sleep and flat feet were major factors affecting their recovery. By improving sleep and using arch supports, they saw significant relief in just 10 days. Now resuming peptides, they express optimism for better results and commit to providing more frequent updates. The speaker emphasizes personal responsibility in optimizing treatment outcomes.
Takeaways
- đȘ The speaker started peptide therapy (BPC 157 and TB500) over two months ago to address worsening knee and ankle issues.
- đŠ” Their knee and ankle pain had been affecting not just workouts but also daily activities like walking and getting out of cars.
- đ€ The speaker partnered with Merik Health for their peptide treatment, which included receiving peptides, labs, and guidance, but no cash exchange.
- đïžââïž The peptides improved their joint recovery and strength, allowing them to perform exercises they hadn't done in years, like heavy deadlifts and certain kicks.
- đ Despite the improvements in strength, the speaker still experienced stiffness and soreness, prompting them to pause peptide use for further assessment.
- đŽ The speaker identified two major lifestyle factors affecting their recovery: lack of sleep (only 4-5 hours per night) and flat feet, which they decided to address.
- đ They began using arch-supporting inserts in their barefoot shoes and house shoes to correct flat feet, which made a significant difference.
- đ Adding 1-1.5 hours of sleep per night and supporting their feet drastically improved mobility, comfort, and overall well-being in just 10 days.
- đ After noticing these improvements, the speaker decided to resume peptide therapy, believing they had now created the right conditions for the peptides to work more effectively.
- đ The speaker plans to provide more frequent updates on their peptide therapy progress and remains committed to being transparent, even if the treatment doesn't yield expected results.
Q & A
What peptides did the speaker start using over two months ago?
-The speaker started using BPC 157 and TB500 peptides over two months ago.
What issues was the speaker experiencing before starting peptide therapy?
-The speaker was experiencing worsening knee pain, swollen and stiff ankles, and overall joint pain, which affected daily activities like walking and getting out of cars.
Why did the speaker decide to stop using the peptides temporarily?
-The speaker stopped using the peptides temporarily because they were still experiencing stiffness and soreness, despite improvements in joint tolerance and strength. They wanted to create a better environment for the peptides to work effectively.
What were the two major changes the speaker made to their lifestyle?
-The speaker made two major changes: increasing their sleep duration from less than 5 hours to more, and using arch-supporting inserts in their shoes to address their flat feet.
How did these changes impact the speaker's overall well-being?
-These changes significantly improved the speaker's mobility, functionality, comfort, and psychological well-being. They reported reduced pain in their ankles, toes, and other joints.
Why does the speaker believe that the peptides did not work as effectively before?
-The speaker believes the peptides did not work effectively because their joint surfaces were not properly supported due to lack of sleep and collapsed arches, which prevented proper healing and restoration.
What improvements did the speaker notice after using the peptides initially?
-The speaker noticed improvements in strength and ability to perform exercises that were difficult before, such as throwing certain kicks and lifting heavy weights.
What was the speaker's concern that led to stopping the peptides?
-The speaker was concerned that despite increased joint tolerance, they were still experiencing stiffness and soreness, which led them to believe there were underlying issues not addressed by the peptides.
How has the speaker's pain level changed after implementing the new lifestyle changes?
-The speaker reported a 90% reduction in body pain and no longer felt they had an autoimmune disorder, attributing this improvement to increased sleep and proper arch support.
What is the speaker's relationship with Merik Health, and are they financially compensated?
-Merik Health provides the peptides, labs, and guidance for the speaker, but there is no financial compensation involved. The speaker emphasizes that they will share honest results regardless of the outcome.
Outlines
Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.
Améliorer maintenantMindmap
Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.
Améliorer maintenantKeywords
Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.
Améliorer maintenantHighlights
Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.
Améliorer maintenantTranscripts
Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.
Améliorer maintenantVoir Plus de Vidéos Connexes
5.0 / 5 (0 votes)